NAD+ Injection Dosage Chart: How Much & How Often (IV, IM, SubQ)

NAD+ injection dosing depends on the route. Based on patient needs, NAD+ may be prescribed for intravenous (IV), intramuscular (IM), or subcutaneous (SubQ) administration. Typical starting doses are 250–500 mg weekly by IV, 50 mg up to three times a week by IM, and 30 mg daily by SubQ. Below you’ll find a full breakdown of each route for Olympia’s 100 mg/mL and 200 mg/mL NAD+ injections, including how to convert syringe units to milligrams and what NAD+ dosage per day looks like.

Important: NAD+ dosing is individualized and will vary depending on patient needs. Use this chart as an educational overview and follow the plan created with your licensed healthcare professional. This chart, and this blog, are for informational purposes only, and not intended to substitute or replace medical advice.

Quick NAD+ Dosage Chart (IV, IM, SubQ)

Concentration:
100 mg/mL (NAD+ Injection)

Route	Starting / Typical Dose	Frequency	Notes
IV infusion	250 mg (2.5 mL) in 500 mL NS over 2 hours	Weekly
IV infusion	500 mg (5 mL) in 1000 mL NS over 4 hours	Weekly	Extended infusion time for patient monitoring
IM injection	50 mg (0.5 mL or 50 units)	Up to 3×/week	Per clinical direction, this will be spaced out across the week.
SubQ Injection	Start 30 units (0.3 mL) daily for ≥1 week	Daily	If desired after the first week, increase to 50 units (0.5 mL) from Monday–Friday only.

Concentration:
200 mg/mL (NAD+ Injection)

Route	Starting / Typical Dose	Frequency	Notes
IV infusion	250 mg (1.25 mL) in 500 mL NS	Weekly
IV infusion	500 mg (2.5 mL) in 1000 mL NS	Weekly	Extended infusion time for patient monitoring
IM injection	50 mg (0.5 mL or 50 units)	Up to 3×/week	Per clinical direction, this will be spaced out across the week.
SubQ Injection	Start 15 units (30 mg) daily	Seven days/week	If desired after the first week, increase to 25 units (50 mg) from Monday–Friday only.

NAD Dosage Per Day: What That Looks Like

Because the IV and IM plans are weekly, “per day” typically applies to the SubQ route of administration:

• Start: 30 units daily for at least one week.
  • With 100 mg/mL, 0.3 mL = 30 mg (because 100 mg × 0.3 mL = 30 mg).
  • Over 7 days, that’s 30 mg/day × 7 = 210 mg/week.
• Then (if desired): 50 units Monday-Friday only.
  • With 100 mg/mL, 0.5 mL = 50 mg (100 mg × 0.5 mL = 50 mg).
  • Over the workweek, that’s 50 mg/day × 5 = 250 mg/week (with weekends off).

For context (weekly totals):

• IM up to 3×/week: 50 mg × 3 = 150 mg/week.
• IV (weekly): 250 mg/week or 500 mg/week, depending on the infusion length/volume.

Your prescriber may keep you at the initial daily SubQ level longer or step you up, depending on your goals and how you feel during and after administrations.

How to Read the Chart: mL, “Units,” and mg

• The guide lists “units” alongside mL for syringe readability (e.g., 50 units = 0.5 mL, 30 units = 0.3 mL).
• With 100 mg/mL, you can convert volume to dose quickly:
  • 0.3 mL → 30 mg
  • 0.5 mL → 50 mg
  • 2.5 mL → 250 mg
  • 5 mL → 500 mg

Olympia’s NAD+ Concentrations

Olympia Pharmaceuticals compounds NAD+ injections in 100mg/mL and 200mg/mL.

How to Choose an NAD+ Route: IV vs IM vs SubQ

Each route follows a different schedule. How often you want to dose is part of choosing the right one.

• IV is often selected for structured weekly sessions in clinic settings.
• IM up to 3×/week provides less frequent, moderate dosing.
• SubQ daily enables smaller, more frequent amounts with the ability to increase after the first week, depending on clinical direction.
  • Check our guide on how to give a SubQ injection

Your clinician will consider your schedule, tolerance during and after administration, and your program goals when recommending route and frequency.

Storage & Handling Notes

• Olympia’s compounded NAD+ injections are liquid formulas, and should be stored under refrigeration. Protect from light.
• Always read the label of your medication prior to administering an injection.

This content is for educational purposes only and is not a substitute for advice from a licensed medical provider. The information here has been written in reference to Olympia’s NAD+ 100mg/mL injection and NAD+ 200mg/mL injection only. Content written here should not be applied to other compounded injections of NAD+. All compounded formulations are prepared by Olympia Pharmaceuticals under cGMP practices and with oversight by national and state pharmacy boards.